Other Viruses Citation List: July 31 - August 13, 2015
Hepatitis B Virus
1. Development of Novel Hepatitis B Virus Capsid Inhibitor Using in Silico Screening. Hayakawa, M., H. Umeyama, M. Iwadate, T. Tanahashi, Y. Yano, M. Enomoto, A. Tamori, N. Kawada, and Y. Murakami. Biochemical and Biophysical Research Communications, 2015. 463(4): p. 1165-1175. PMID[26095852].
[PubMed]. OV_0731-081315.
2. Bioactivity-guided Isolation of anti-Hepatitis B Virus Active Sesquiterpenoids from the Traditional Chinese Medicine: Rhizomes of Cyperus rotundus. Xu, H.B., Y.B. Ma, X.Y. Huang, C.A. Geng, H. Wang, Y. Zhao, T.H. Yang, X.L. Chen, C.Y. Yang, X.M. Zhang, and J.J. Chen. Journal of Ethnopharmacology, 2015. 171: p. 131-140. PMID[26051832].
[PubMed]. OV_0731-081315.
3. Isolation and anti-Hepatitis B Virus Activity of Dibenzocyclooctadiene ignans from the Fruits of Schisandra chinensis. Xue, Y., X. Li, X. Du, X. Li, W. Wang, J. Yang, J. Chen, J. Pu, and H. Sun. Phytochemistry, 2015. 116: p. 253-261. PMID[25882501].
[PubMed]. OV_0731-081315.
Hepatitis C Virus
4. Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase. Furuta, A., M. Tsubuki, M. Endoh, T. Miyamoto, J. Tanaka, K.A. Salam, N. Akimitsu, H. Tani, A. Yamashita, K. Moriishi, M. Nakakoshi, Y. Sekiguchi, S. Tsuneda, and N. Noda. International Journal of Molecular Sciences, 2015. 16(8): p. 18439-18453. PMID[26262613].
[PubMed]. OV_0731-081315.
Citations from the ISI Web of Knowledge Listings for O.V.
5. Structure-Activity Relationships of Neplanocin A Analogues as S-Adenosylhomocysteine hydrolase Inhibitors and their Antiviral and Antitumor Activities. Chandra, G., Y.W. Moon, Y. Lee, J.Y. Jang, J. Song, A. Nayak, K. Oh, V.A. Mulamoottil, P.K. Sahu, G. Kim, T.S. Chang, M. Noh, S.K. Lee, S. Choi, and L.S. Jeong. Journal of Medicinal Chemistry, 2015. 58(12): p. 5108-5120. ISI[000357139000021].
[WOS]. OV_0731-081315.
6. Irbesartan, an FDA Approved Drug for Hypertension and Diabetic Nephropathy, is a Potent Inhibitor for Hepatitis B Virus Entry by Disturbing Na+-dependent Taurocholate Cotransporting Polypeptide Activity. Wang, X.J., W. Hu, T.Y. Zhang, Y.Y. Mao, N.N. Liu, and S.Q. Wang. Antiviral Research, 2015. 120: p. 140-146. ISI[000358099000019].
[WOS]. OV_0731-081315.